Related Experiment Video
Updated: Jul 12, 2026

A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
Impact of cardiac rehabilitation on depression and its associated mortality
Richard V Milani1, Carl J Lavie
1Department of Cardiology, Ochsner Medical Center, New Orleans, La 70121, USA. rmilani@ochsner.org
Insights
Cardiac rehabilitation significantly reduces depressive symptoms in coronary patients. This intervention also lowers the excess mortality associated with depression after cardiac events, even with modest fitness improvements.
Area of Science:
- Cardiology
- Psychiatry
- Rehabilitation Medicine
Background:
- Depression post-cardiac events correlates with increased mortality.
- The efficacy of cardiac rehabilitation in mitigating this depression-related mortality is not well-established.
Purpose of the Study:
- To assess the impact of cardiac rehabilitation on depression in coronary patients.
- To determine if cardiac rehabilitation reduces depression-associated mortality.
Main Methods:
- A cohort of 522 coronary patients undergoing cardiac rehabilitation was compared to 179 controls.
- Depressive symptoms were measured pre- and post-rehabilitation.
- Mortality was tracked over a mean follow-up of 1296 days.
Main Results:
- Depressive symptoms decreased by 63% post-rehabilitation (17% to 6%).
- Depressed patients completing rehabilitation had 73% lower mortality compared to controls.
- Reductions in depression and mortality were linked to fitness improvements, with modest gains being sufficient.
Conclusions:
- Cardiac rehabilitation effectively reduces depressive symptoms in patients after coronary events.
- The intervention significantly lowers the excess mortality linked to post-event depression.
- Even minor improvements in physical fitness during rehabilitation yield substantial benefits for depression and mortality.
Purpose:
Depression following major cardiac events is associated with higher mortality, but little is known about whether this can be reduced through treatment including cardiac rehabilitation and exercise training. We evaluated the impact of cardiac rehabilitation on depression and its associated mortality in coronary patients.
Patients And Methods:
We evaluated 522 consecutive coronary patients (381 men, 141 women; aged 64+/-10 years) enrolled in cardiac rehabilitation from January 2000 to July 2005 and a control group of 179 patients not completing rehabilitation. Depressive symptoms were assessed by questionnaire at baseline and following rehabilitation, and mortality was evaluated after a mean follow-up of 1296+/-551 days.
Results:
Prevalence of depressive symptoms decreased 63% following rehabilitation, from 17% to 6% (P <.0001). Depressed patients following rehabilitation had an over 4-fold higher mortality than nondepressed patients (22% vs 5%, P=.0004). Depressed patients who completed rehabilitation had a 73% lower mortality (8% vs 30%; P=.0005) compared with control depressed subjects who did not complete rehabilitation. Reductions in depressive symptoms and its associated mortality were related to improvements in fitness; however, similar reductions were noted in those with either modest or marked increases in exercise capacity.
Conclusion:
In patients following major coronary events, cardiac rehabilitation is associated with both reductions in depressive symptoms and the excess mortality associated with it. Moreover, only mild improvements in levels of fitness appear to be needed to produce these benefits on depressive symptoms and its associated mortality.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease V: Interprofessional Care